Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study

被引：0
作者：
Luca Triggiani
Filippo Alongi
Michela Buglione
Beatrice Detti
Riccardo Santoni
Alessio Bruni
Ernesto Maranzano
Frank Lohr
Rolando D’Angelillo
Alessandro Magli
Alberto Bonetta
Rosario Mazzola
Nadia Pasinetti
Giulio Francolini
Gianluca Ingrosso
Fabio Trippa
Sergio Fersino
Paolo Borghetti
Paolo Ghirardelli
Stefano Maria Magrini
机构：
[1] University and Spedali Civili Hospital,Department of Radiation Oncology
[2] Sacro Cuore Don Calabria Cancer Care Center,Department of Radiation Oncology
[3] A.O.U Careggi,Department of Radiation Oncology
[4] University of Florence,Department of Radiation Oncology
[5] Policlinico Tor Vergata,Department of Radiation Oncology
[6] University of Rome,Department of Radiation Oncology
[7] AOU Policlinico Modena,Department of Radiation Oncology
[8] ‘S. Maria’ Hospital,Department of Radiation Oncology
[9] Campus Biomedico University,Department of Radiation Oncology
[10] ‘Santa Maria della Misericordia’ Hospital,undefined
[11] Cremona Hospital,undefined
来源：
British Journal of Cancer | 2017年 / 116卷
关键词：
oligometastases; prostate cancer; SBRT; SABR; radiotherapy; androgen deprivation therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1520 / 1525
页数：5
相关论文
共 209 条
  • [1] Ahmed KA(2013)Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer Front Oncol 2 215-1107
  • [2] Barney BM(2012)Review and uses of stereotactic body radiation therapy for oligometastases Oncologist 17 1100-433
  • [3] Davis BJ(2014)Enzalutamide in metastatic prostate cancer before chemotherapy; PREVAIL Investigators N Engl J Med 371 424-55
  • [4] Park SS(2011)Efficacy of eradicative radiotherapy for limited nodal metastases detected with choline PET scan in prostate cancer patients Tumori 97 49-571
  • [5] Kwon ED(2012)Advanced clinical states in prostate cancer Urol Clin North Am 39 561-642
  • [6] Olivier KR(2017)EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer Eur Urol 71 630-974
  • [7] Alongi F(1998)Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 969-247
  • [8] Arcangeli S(2014)Choline-PET in prostate cancer management: the point of view of the radiation oncologist Crit Rev Oncol Hematol 91 234-145
  • [9] Filippi AR(2014)Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence Radiat Oncol 9 135-823
  • [10] Ricardi U(2008)Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02 Eur Urol 54 816-85
12345678910